Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease
Authors
Keywords
Alzheimer’s disease, Blood-based biomarker, microRNA, miR-501-3p, Next-generation sequencing, Autopsied brain, Braak staging
Journal
Acta Neuropathologica Communications
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-31
DOI
10.1186/s40478-017-0414-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine
- (2016) Rachel E. Crossland et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Plasma microRNA biomarkers for detection of mild cognitive impairment: Biomarker Validation Study
- (2016) Kira S. Sheinerman et al. Aging-US
- Neuronal cell cycle: the neuron itself and its circumstances
- (2015) José M Frade et al. CELL CYCLE
- miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregationin vivo
- (2015) Pascal Y. Smith et al. HUMAN MOLECULAR GENETICS
- miR-501-3p mediates the activity-dependent regulation of the expression of AMPA receptor subunit GluA1
- (2015) Zhonghua Hu et al. JOURNAL OF CELL BIOLOGY
- Genomic integrity and the ageing brain
- (2015) Hei-man Chow et al. NATURE REVIEWS NEUROSCIENCE
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers
- (2015) Giovanni Lugli et al. PLoS One
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer
- (2014) S Zanutto et al. BRITISH JOURNAL OF CANCER
- MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease
- (2014) J. Banzhaf-Strathmann et al. EMBO JOURNAL
- Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment
- (2014) L Cheng et al. MOLECULAR PSYCHIATRY
- The future of blood-based biomarkers for Alzheimer's disease
- (2013) Kim Henriksen et al. Alzheimers & Dementia
- Alteration of the microRNA network during the progression of Alzheimer's disease
- (2013) Pierre Lau et al. EMBO Molecular Medicine
- De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease
- (2013) Hon-Kit Andus Wong et al. HUMAN MOLECULAR GENETICS
- MiR-26b, Upregulated in Alzheimer's Disease, Activates Cell Cycle Entry, Tau-Phosphorylation, and Apoptosis in Postmitotic Neurons
- (2013) S. Absalon et al. JOURNAL OF NEUROSCIENCE
- miRBase: annotating high confidence microRNAs using deep sequencing data
- (2013) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Circulating miRNA Biomarkers for Alzheimer's Disease
- (2013) Pavan Kumar et al. PLoS One
- A blood based 12-miRNA signature of Alzheimer disease patients
- (2013) Petra Leidinger et al. GENOME BIOLOGY
- Method for microRNA isolation from clinical serum samples
- (2012) Yu Li et al. ANALYTICAL BIOCHEMISTRY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Comparing the MicroRNA Spectrum between Serum and Plasma
- (2012) Kai Wang et al. PLoS One
- Biomarkers in Alzheimer's disease drug development
- (2011) Jeffrey L. Cummings Alzheimers & Dementia
- Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease
- (2011) Hirosha Geekiyanage et al. EXPERIMENTAL NEUROLOGY
- MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid , Novel Targets in Sporadic Alzheimer's Disease
- (2011) H. Geekiyanage et al. JOURNAL OF NEUROSCIENCE
- Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What
- (2011) Russell H. Swerdlow NEUROTOXICITY RESEARCH
- Haemolysis during Sample Preparation Alters microRNA Content of Plasma
- (2011) Michaela B. Kirschner et al. PLoS One
- Pathological implications of cell cycle re-entry in Alzheimer disease
- (2010) David J. Bonda et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation
- (2010) Juan Nunez-Iglesias et al. PLoS One
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of -Site Amyloid Precursor Protein-Cleaving Enzyme 1
- (2008) W.-X. Wang et al. JOURNAL OF NEUROSCIENCE
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
- Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/ -secretase expression
- (2008) S. S. Hebert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More